Novartis Investigative Site

Ebersbach 02730

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients — Completed